Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Le Tallec
Cervarix™, the GSK HPV-16/HPV-18 AS04-adjuvanted Cervical Cancer Vaccine, Demonstrates Stability Upon Long-Term Storage and Under Simulated Cold Chain Break Conditions
Human Vaccines
Related publications
Erratum To: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
Open Forum Infectious Diseases
Oncology
Neurology
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
Drugs
Pharmacology
Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
PLoS ONE
Multidisciplinary
PS1-25: The Impact of HPV Vaccination Upon Optimal Cervical Cancer Screening Strategies
Clinical Medicine and Research
Medicine
Home Care
Community
Efficacy, Immunogenicity and Safety of the AS04‐HPV‐16/18 Vaccine in Chinese Women Aged 18‐25 Years: End‐of‐study Results From a Phase II/III, Randomised, Controlled Trial
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Cervical Cancer in Women With HPV
Amadeus International Multidisciplinary Journal
Cervical Cancer and Human Papilloma Virus (HPV) – Viral Cervical Cancer
MOJ Cell Science & Report
